An opportunity to address the genetic causes of birth defects

Pediatric Research

Volumn 81, Issue 2, 2017, Pages 282-285

  Khokha, Mustafa K ^a   Mitchell, Laura E ^b   Wallingford, John B ^c  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHILDHOOD CANCER; COMPREHENSION; CONGENITAL MALFORMATION; COST; DISEASE ASSOCIATION; GENETIC ANALYSIS; GENETICS; HUMAN; MEDICAL RESEARCH; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PUBLIC HEALTH; SOCIETY; ANIMAL; CONGENITAL DISORDER; GENETIC PREDISPOSITION; NEWBORN; PATIENT CARE;

ANIMALS; CONGENITAL ABNORMALITIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; PATIENT CARE TEAM;

EID: 85012934011     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1038/pr.2016.229     Document Type: Note

References (14)

1. Christianson A, Howson CP, Modell B. March of Dimes global report on birth defects. White Plains, New York: March of Dimes Research Foundation; 2006.
2. Gregory EC, MacDorman MF. Fetal and Perinatal Mortality: United States, 2013. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System. 2015;64:1-24.
3. Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA 2011;306:2459-68.
4. Yoon P W, Olney RS, Khoury MJ, Sappenfeld WM, Chavez GF, Taylor D. Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study. Arch Pediatr Adolesc Med 1997;151:1096-103.
5. Waitzman NJ, Romano PS, Schefer RM. Estimates of the economic costs of birth defects. Inquiry 1994;31:188-205.
6. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statistics-2003. Pediatrics 2005;115:619-34.
7. United States Department of Health and Human Services. Deaths: Final Data for 2013. (Table 10). (http://www.cdc.gov/nchs/data/nvsr/nvsr64/ nvsr64-02.pdf).
8. Fisher PG, Reynolds P, Von Behren J, Carmichael SL, Rasmussen SA, Shaw GM. Cancer in children with nonchromosomal birth defects. J Pedi-atr 2012;160:978-83.
9. Botto LD, Flood T, Little J, et al. Cancer risk in children and adolescents with birth defects: a population-based cohort study. PLoS One 2013;8: e69077.
10. Carozza SE, Langlois PH, Miller EA, Canfeld M. Are children with birth defects at higher risk of childhood cancers? Am J Epidemiol 2012;175:1217-24.
11. Gelb B, Brueckner M, Chung W, et al.; Pediatric Cardiac Genomics Consortium. The Congenital Heart Disease Genetic Network Study: rationale, design, and early results. Circ Res 2013;112:698-706.
12. Fakhro KA, Choi M, Ware SM, et al. Rare copy number variations in congenital heart disease patients identify unique genes in lef-right patterning. Proc Natl Acad Sci USA 2011;108:2915-20.
13. Glessner JT, Bick AG, Ito K, et al. Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data. Circ Res 2014;115:884-96.
14. Zaidi S, Choi M, Wakimoto H, et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 2013;498:220-3.